Protalix BioTherapeutics (PLX) Earnings Date & Reports

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs... Show more

Industry: #Servicestothe Health Industry

Get AI intraday signals

A.I. Advisor

published Earnings

PLX is expected to report earnings to fall 45.45% to 11 cents per share on August 17

Protalix BioTherapeutics PLX Stock Earnings Reports

Q2'26

Est.

$0.12

Q1'26

Beat

by $0.18

Q4'25

Missed

by $0.11

Q3'25

Missed

by $0.04

Q2'25

Missed

by $0.15

The last earnings report on May 13 showed earnings per share of 21 cents, beating the estimate of 3 cents. With 99.02K shares outstanding, the current market capitalization sits at 159.53M.

View a ticker or compare two or three

Compare

PLX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for PLX